Retatide, scientifically known as Retatrutide, is a cutting-edge research peptide that functions as a triple agonist — targeting GLP-1, GIP, and Glucagon receptors. This multi-receptor activity makes it one of the most promising candidates in ongoing studies related to weight loss, insulin resistance, and metabolic regulation.

Unlike single-pathway peptides like Semaglutide, Retatide stimulates multiple metabolic routes, potentially offering stronger appetite suppression, improved energy balance, and enhanced fat-burning capabilities in clinical models. Researchers are particularly interested in how it mimics natural hormonal responses without overstimulation — a critical factor in long-term obesity management trials.

Retatide is currently available in 30 mg vials for research use only. All batches are independently tested to ensure purity, identity, and consistency. At GLP Journey, we are proud to offer this compound for regulated lab use, packaged securely and delivered quickly across the UK.

As always, we remind our clients: this product is not intended for human consumption or therapeutic use. It is strictly for laboratory research purposes.